{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:59:41Z","timestamp":1786550381168,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Aging","award":["AG026572"],"award-info":[{"award-number":["AG026572"]}]},{"name":"Analytic Core"},{"DOI":"10.13039\/100001269","name":"Kenneth T and Eileen L Norris Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.neurobiolaging.2009.12.010","type":"journal-article","created":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T09:16:40Z","timestamp":1262855800000},"page":"1949-1963","source":"Crossref","is-referenced-by-count":109,"title":["17\u03b2-Estradiol regulates insulin-degrading enzyme expression via an ER\u03b2\/PI3-K pathway in hippocampus: Relevance to Alzheimer's prevention"],"prefix":"10.1016","volume":"32","author":[{"given":"Liqin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zisu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Diaz","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib1","first-page":"149","article-title":"Insulin-degrading enzyme","volume":"19","author":"Authier","year":"1996","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(99)00135-4","article-title":"Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques","volume":"263","author":"Bernstein","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib3","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1126\/science.290.5500.2302","article-title":"Evidence for genetic linkage of Alzheimer's disease to chromosome 10q","volume":"290","author":"Bertram","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/01.WNL.0000129987.70037.DB","article-title":"Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese","volume":"63","author":"Bian","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib5","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.neurobiolaging.2006.06.017","article-title":"Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE","volume":"28","author":"Bjork","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.tins.2008.07.003","article-title":"The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications","volume":"31","author":"Brinton","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tips.2008.12.006","article-title":"Estrogen-induced plasticity from cells to circuits: predictions for cognitive function","volume":"30","author":"Brinton","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0197-4580(00)00109-3","article-title":"The Women's Health Initiative estrogen replacement therapy is neurotrophic and neuroprotective","volume":"21","author":"Brinton","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2004-6302","article-title":"Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4","volume":"6","author":"Burkhardt","year":"2004","journal-title":"J. Alzheimer Dis."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neurobiolaging.2004.06.013","article-title":"Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders","volume":"26","author":"Caccamo","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib11","article-title":"Alzheimer's plaques and tangles: a controlled and enhanced silver staining method","volume":"13","author":"Campbell","year":"1987","journal-title":"Soc. Neurosci. Abstracts"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib12","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1202-793","article-title":"Serum insulin-like growth factor I regulates brain amyloid-beta levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib13","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.1523\/JNEUROSCI.2718-07.2007","article-title":"Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice","volume":"27","author":"Carroll","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1096\/fj.00-0398com","article-title":"Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex","volume":"15","author":"Cheng","year":"2001","journal-title":"FASEB J."},{"issue":"Pt 2","key":"10.1016\/j.neurobiolaging.2009.12.010_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/0264-6021:3510509","article-title":"Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization","volume":"351","author":"Chesneau","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib16","first-page":"608","article-title":"Insulin degradation: progress and potential","volume":"19","author":"Duckworth","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1042\/BST20051101","article-title":"Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention","volume":"33","author":"Eckman","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib18","doi-asserted-by":"crossref","first-page":"13389","DOI":"10.1074\/jbc.M111571200","article-title":"Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD)","volume":"277","author":"Edbauer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(03)00488-9","article-title":"Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE)","volume":"345","author":"Edland","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib20","first-page":"1121","article-title":"The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease","volume":"115","author":"Gandy","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 1","key":"10.1016\/j.neurobiolaging.2009.12.010_bib21","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.psyneuen.2007.03.001","article-title":"Estradiol, insulin-like growth factor-I and brain aging","volume":"32","author":"Garcia-Segura","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib22","first-page":"1174","article-title":"The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes","volume":"67","author":"Ghosh","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib23","doi-asserted-by":"crossref","first-page":"12128","DOI":"10.1074\/jbc.M110009200","article-title":"Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis","volume":"277","author":"Greenfield","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.med.55.091902.103607","article-title":"Toward Alzheimer therapies based on genetic knowledge","volume":"55","author":"Hardy","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.0.CO;2-T","article-title":"Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons","volume":"60","author":"Honda","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib27","doi-asserted-by":"crossref","first-page":"13065","DOI":"10.1016\/S0021-9258(17)36796-0","article-title":"Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein","volume":"269","author":"Jaffe","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib28","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1210\/mend-5-10-1467","article-title":"Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway","volume":"5","author":"Kuo","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1210\/endo.132.2.7678795","article-title":"Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues","volume":"132","author":"Kuo","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0968-0004(01)01876-X","article-title":"Insulin-degrading enzyme: embarking on amyloid destruction","volume":"26","author":"Kurochkin","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)00387-4","article-title":"Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme","volume":"345","author":"Kurochkin","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib32","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/01.jnen.0000235853.70092.ba","article-title":"Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology","volume":"65","author":"Leal","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib33","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1523\/JNEUROSCI.1443-06.2006","article-title":"Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signal-regulated kinase 1\/2 in the same population of cortical neurons: a unified mechanism of estrogen action","volume":"26","author":"Mannella","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib34","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1021\/jm010254a","article-title":"Estrogen receptor-beta potency-selective ligands: structure\u2013activity relationship studies of diarylpropionitriles and their acetylene and polar analogues","volume":"44","author":"Meyers","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib35","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1523\/JNEUROSCI.20-23-08745.2000","article-title":"Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques","volume":"20","author":"Mukherjee","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2174\/156720508783954785","article-title":"Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease","volume":"5","author":"Nalivaeva","year":"2008","journal-title":"Curr. Alzheimer. Res."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1007527721160","article-title":"Degradation of soluble amyloid beta-peptides 1\u201340, 1\u201342, and the Dutch variant 1\u201340Q by insulin degrading enzyme from Alzheimer disease and control brains","volume":"25","author":"Perez","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib39","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1212\/WNL.54.12.2212","article-title":"Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain","volume":"54","author":"Petanceska","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib40","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.ejhg.5201447","article-title":"Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women","volume":"13","author":"Pirskanen","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(00)01221-0","article-title":"Expression of estrogen receptor-beta protein and mRNA in the cerebellum of the rat","volume":"288","author":"Price","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib42","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation","volume":"273","author":"Qiu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib43","first-page":"1","article-title":"Type II diabetes in American Women over 40: obesity and menopause","volume":"6","author":"Revis","year":"2007","journal-title":"Internet J. Health"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib44","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0197-4580(98)00033-5","article-title":"Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid","volume":"19","author":"Saido","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","article-title":"Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"924","author":"Selkoe","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","article-title":"Clearing the brain's amyloid cobwebs","volume":"32","author":"Selkoe","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6","article-title":"Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system","volume":"388","author":"Shughrue","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0306-4522(99)00520-5","article-title":"Estrogen binding and estrogen receptor characterization (ERalpha and ERbeta) in the cholinergic neurons of the rat basal forebrain","volume":"96","author":"Shughrue","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib49","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1021\/jm000170m","article-title":"Pyrazole ligands: structure-affinity\/activity relationships and estrogen receptor-alpha-selective agonists","volume":"43","author":"Stauffer","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib50","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0014-4886(03)00215-2","article-title":"Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17beta estradiol","volume":"183","author":"Struble","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib51","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/endo.140.2.6480","article-title":"Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta","volume":"140","author":"Sun","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib52","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib53","first-page":"605","article-title":"Clearance of Alzheimer's Abeta peptide: the many roads to perdition","volume":"43","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1126\/science.301.5629.40","article-title":"Insulin insults may spur Alzheimer's disease","volume":"301","author":"Taubes","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/153537020523000706","article-title":"Androgen- and estrogen-dependent regulation of insulin-degrading enzyme in subcellular fractions of rat prostate and uterus","volume":"230","author":"Udrisar","year":"2005","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/jmg.2006.048470","article-title":"Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population","volume":"44","author":"Vepsalainen","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/01.WNL.0000134666.64593.BA","article-title":"Diabetes, impaired fasting glucose, and development of cognitive impairment in older women","volume":"63","author":"Yaffe","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib58","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/WNL.54.10.1949","article-title":"Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction","volume":"54","author":"Yaffe","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib59","doi-asserted-by":"crossref","first-page":"19198","DOI":"10.1073\/pnas.0505203102","article-title":"Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model","volume":"102","author":"Yue","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib60","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/00001756-200107030-00030","article-title":"Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt","volume":"12","author":"Zhang","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ddr.20049","article-title":"Estrogen receptor beta as a therapeutic target for promotion of neurogenesis and prevention of neurodegeneration","volume":"66","author":"Zhao","year":"2006","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2007.06.092","article-title":"Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons","volume":"1172","author":"Zhao","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib63","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1586\/14737175.7.11.1549","article-title":"WHI and WHIMS follow-up and human studies of soy isoflavones on cognition","volume":"7","author":"Zhao","year":"2007","journal-title":"Exp. Rev. Neurother."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib64","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.brainresrev.2005.01.009","article-title":"Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs","volume":"49","author":"Zhao","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib65","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","article-title":"Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention","volume":"24","author":"Zhao","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2004.02.066","article-title":"Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons","volume":"1010","author":"Zhao","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib67","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neurobiolaging.2006.05.001","article-title":"Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease","volume":"28","author":"Zhao","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2009.12.010_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.0022-3042.2001.00690.x","article-title":"Modulation of A(beta) peptides by estrogen in mouse models","volume":"80","author":"Zheng","year":"2002","journal-title":"J. Neurochem."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458009004023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458009004023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T22:58:33Z","timestamp":1634684313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458009004023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0197458009004023"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.12.010","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}